Voyager Therapeutics (VYGR) Leases (2019 - 2025)
Historic Leases for Voyager Therapeutics (VYGR) over the last 7 years, with Q3 2025 value amounting to $29.7 million.
- Voyager Therapeutics' Leases fell 1385.45% to $29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year decrease of 1385.45%. This contributed to the annual value of $33.3 million for FY2024, which is 14684.68% up from last year.
- As of Q3 2025, Voyager Therapeutics' Leases stood at $29.7 million, which was down 1385.45% from $31.0 million recorded in Q2 2025.
- Voyager Therapeutics' 5-year Leases high stood at $39.2 million for Q1 2024, and its period low was $13.5 million during Q4 2023.
- Moreover, its 5-year median value for Leases was $32.1 million (2025), whereas its average is $26.8 million.
- As far as peak fluctuations go, Voyager Therapeutics' Leases plummeted by 5371.81% in 2022, and later skyrocketed by 16108.15% in 2024.
- Quarter analysis of 5 years shows Voyager Therapeutics' Leases stood at $33.5 million in 2021, then crashed by 53.72% to $15.5 million in 2022, then fell by 12.75% to $13.5 million in 2023, then soared by 146.85% to $33.3 million in 2024, then fell by 10.82% to $29.7 million in 2025.
- Its Leases was $29.7 million in Q3 2025, compared to $31.0 million in Q2 2025 and $32.1 million in Q1 2025.